{"success":true,"data":{"pressRelease":{"id":"97133","rtpr_id":"nPn615ZLma","ticker":"GS","exchange":"NYSE","all_tickers":["GS","WP"],"title":"Paradigm Oral Health Announces Surgeon-Led Buyback, Backed by Warburg Pincus-Led Investor Group","author":"PR Newswire","published_at":"2026-07-23T19:00:01.193Z","article_body":"Paradigm Oral Health Announces Surgeon-Led Buyback, Backed by Warburg Pincus-Led Investor Group\n\nPR Newswire\n\nLINCOLN, Neb., July 23, 2026\n\nLINCOLN, Neb., July 23, 2026 /PRNewswire/ -- Paradigm Oral Health (\"Paradigm\"\nor the \"Company\"), a leading oral surgery and digital dentistry platform,\ntoday announced a buyback of BlackRock Long Term Private Capital's\n(\"BlackRock LTPC\") ownership stake, returning majority control to its surgeons\nand management. The transaction is backed by a significant investment led by\nWarburg Pincus, in partnership with Goldman Sachs Alternatives and Sixth\nStreet. It reinforces Paradigm's continued commitment to delivering excellent\nclinical care, investing in innovative technology and advanced training,\nexpanding access through additional clinics, and preserving its surgeon-owned\nand surgeon-led model.\n\nFounded in 2018 by David Rallis, DDS, MD, Paradigm has developed an\nindustry-leading model designed to attract, support and retain best-in-class\noral surgeons. Today, Paradigm operates a network of more than 170\nstate-of-the-art facilities across the United States, with a team of over 220\nsurgeons focused on delivering the highest quality of oral health care and\ndental implant surgery while fostering a medically-driven, patient-friendly\nculture of excellence.\n\n\"This is an important milestone for Paradigm and for the surgeons who have\nbuilt this platform into what it is today,\" said Dr. David Rallis, Founder and\nChief Executive Officer of Paradigm. \"We are excited to partner with Warburg\nPincus and our new investors, who understand the strength of our surgeon-owned\nand surgeon-led model, the quality of our clinical culture and the significant\nopportunity ahead. We are grateful to BlackRock LTPC for their partnership and\nsupport in helping us reach this point and are excited to continue delivering\nexceptional clinical care to patients across the country.\"\n\n\"Paradigm has built a highly differentiated, surgeon-led clinical model that\ncombines excellent patient care with advanced education, robust clinical\ntechnology and a surgeon-first culture. We are thrilled to support Dr. Rallis\nand the Paradigm team in this next phase of growth,\" said Adam Krainson,\nManaging Director, Warburg Pincus. \"This investment reflects our focus on\npartnering with high-quality healthcare businesses that have strong clinical\nfoundations, meaningful growth potential and exceptional leadership teams,\nwhile providing flexible capital to support long-term growth.\" added José\nArredondo, Managing Director, Warburg Pincus. The investment is being made by\nthe Warburg Pincus Capital Solutions Founders Fund (\"WPCS FF\").\n\nJefferies served as financial advisor to the Company and BlackRock LTPC and\nGoodwin Procter LLP served as legal advisor to the Company.  Evercore served\nas financial advisor and Latham & Watkins LLP served as legal advisor to\nWarburg Pincus.\n\nAbout Paradigm Oral Health\n\nParadigm Oral Health is one of the nation's leading organizations for oral\nsurgery, partnering with elite oral surgeons to deliver exceptional patient\ncare through clinical excellence, innovation and education. By combining\nsurgeon leadership with advanced technology, operational support and a\ncommitment to continuous learning, Paradigm is helping shape the future of the\nspecialty while expanding access to world-class care across the United States.\nTo learn more, visit ParadigmOralHealth.com\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4736858-1&h=2005054540&u=http%3A%2F%2Fparadigmoralhealth.com%2F&a=ParadigmOralHealth.com)\nand Pi2edu.com\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4736858-1&h=2484487085&u=http%3A%2F%2Fpi2edu.com%2F&a=Pi2edu.com)\n.\n\nAbout Warburg Pincus\n\nWarburg Pincus LLC is the pioneer of global growth investing. A private\npartnership since 1966, the firm has the flexibility and experience to focus\non helping investors and management teams achieve enduring success across\nmarket cycles. Today, the firm has more than $105 billion in assets under\nmanagement, and more than 225 companies in its active portfolio, diversified\nacross stages, sectors, and geographies. Warburg Pincus has invested in more\nthan 1,100 companies across its private equity, real estate, and capital\nsolutions strategies. Since inception, Warburg Pincus has invested over $20\nbillion in more than 190 innovative healthcare companies around the world,\nincluding Summit Health/CityMD, MB2 Dental, Modernizing Medicine, GHX,\nEnsemble Healthcare Partners, and Bausch + Lomb.\n\nWarburg Pincus Capital Solutions collaborates closely with the firm's 290+\ninvestment professionals and approximately 75 value creation executives to\noffer flexible, solutions-oriented capital across sectors and geographies for\ngrowth, M&A, balance sheet optimization, and shareholder liquidity. The\ngroup works together with domain experts across Warburg Pincus' global\nindustry verticals to source and underwrite bespoke, value additive\ntransactions. Recent investments have included DriveCentric, Cerity Partners,\nExcelitas Technologies, Global Eggs, MB2 Dental, Madison International Realty,\nMIAX, MyKaarma, Nord Security, Service Compression, and United Trust Bank.\n\nThe firm is headquartered in New York with more than 15 offices globally. For\nmore information, please visit www.warburgpincus.com\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4736858-1&h=384082869&u=http%3A%2F%2Fwww.warburgpincus.com%2F&a=www.warburgpincus.com)\n or follow us on LinkedIn\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4736858-1&h=2732283456&u=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fwarburg-pincus%2F&a=LinkedIn)\n and YouTube\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4736858-1&h=4163524688&u=https%3A%2F%2Fwww.youtube.com%2F%40WarburgPincusLLC&a=YouTube)\n.\n\nAbout Goldman Sachs Alternatives\n\nGoldman Sachs (NYSE: GS) is one of the leading investors in alternatives\nglobally, with over $645 billion in assets and more than 30 years of\nexperience. The business invests in the full spectrum of alternatives,\nincluding private equity, growth equity, private credit, real estate,\ninfrastructure, sustainability, and hedge funds. Clients access these\nsolutions through direct strategies, customized partnerships, and\nopen-architecture programs.\n\nThe business is driven by a focus on partnership and shared success with its\nclients, seeking to deliver long-term investment performance drawing on its\nglobal network and deep expertise across industries and markets.\n\nThe alternative investments platform is part of Goldman Sachs Asset\nManagement, which delivers investment and advisory services across public and\nprivate markets for the world's leading institutions, financial advisors and\nindividuals. Goldman Sachs has more than $4 trillion in assets under\nsupervision globally as of June 30, 2026. Follow us on LinkedIn\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4736858-1&h=1670519697&u=https%3A%2F%2Furldefense.com%2Fv3%2F__https%3A%2Fwww.linkedin.com%2Fshowcase%2Fgoldman-sachs-assetmanagement%2F__%3B!!C6_QoRJkNIGUjYo!CXd3F92FRX-w1ePgdYUA8p-Xp_nE0U_tINqhg4K0ZFWIexKhEHUwGuth637FNta98jlNzES4k--fm5CdMoSeXx4l2LAEYdFo%24&a=LinkedIn)\n.\n\nAbout Sixth Street\n\nSixth Street is a global investment firm with over $135 billion in assets\nunder management and committed capital. Sixth Street uses its long-term\nflexible capital, data-enabled capabilities, and One Team culture to develop\nthemes and offer solutions to companies across all stages of growth. Sixth\nStreet Healthcare and Life Sciences invests thematically throughout the\nhealthcare ecosystem, providing flexible capital solutions to companies\naddressing our most pressing healthcare challenges and improving patient\noutcomes. Founded in 2009, Sixth Street has more than 750 team members\nincluding approximately 300 investment professionals around the world. For\nmore information, visit www.sixthstreet.com\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4736858-1&h=383106585&u=http%3A%2F%2Fwww.sixthstreet.com%2F&a=www.sixthstreet.com)\n, and follow Sixth Street on LinkedIn\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4736858-1&h=4029458253&u=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fsixthstreet%2F&a=LinkedIn)\n.\n\nContact\n\nParadigm Oral Health\n\nWill Garin\n\nWill.Garin@paradigmoralhealth.com (mailto:Will.Garin@paradigmoralhealth.com)\n\nWarburg Pincus\n\nSarah Bloom, Director, Communications\n\nsarah.bloom@warburgpincus.com (mailto:sarah.bloom@warburgpincus.com)\n\nView original\ncontent:https://www.prnewswire.com/news-releases/paradigm-oral-health-announces-surgeon-led-buyback-backed-by-warburg-pincus-led-investor-group-302832427.html\n(https://www.prnewswire.com/news-releases/paradigm-oral-health-announces-surgeon-led-buyback-backed-by-warburg-pincus-led-investor-group-302832427.html)\n\nSOURCE Warburg Pincus LLC\n\n\n\nCopyright (c) 2026 PR Newswire Association,LLC. All Rights Reserved.","article_body_html":"","raw_payload":{"data":{"id":"nPn615ZLma","title":"Paradigm Oral Health Announces Surgeon-Led Buyback, Backed by Warburg Pincus-Led Investor Group","author":"PR Newswire","ticker":"GS","created":"2026-07-23T19:00:01.193Z","tickers":["GS","WP"],"exchange":"NYSE","article_body":"Paradigm Oral Health Announces Surgeon-Led Buyback, Backed by Warburg Pincus-Led Investor Group\n\nPR Newswire\n\nLINCOLN, Neb., July 23, 2026\n\nLINCOLN, Neb., July 23, 2026 /PRNewswire/ -- Paradigm Oral Health (\"Paradigm\"\nor the \"Company\"), a leading oral surgery and digital dentistry platform,\ntoday announced a buyback of BlackRock Long Term Private Capital's\n(\"BlackRock LTPC\") ownership stake, returning majority control to its surgeons\nand management. The transaction is backed by a significant investment led by\nWarburg Pincus, in partnership with Goldman Sachs Alternatives and Sixth\nStreet. It reinforces Paradigm's continued commitment to delivering excellent\nclinical care, investing in innovative technology and advanced training,\nexpanding access through additional clinics, and preserving its surgeon-owned\nand surgeon-led model.\n\nFounded in 2018 by David Rallis, DDS, MD, Paradigm has developed an\nindustry-leading model designed to attract, support and retain best-in-class\noral surgeons. Today, Paradigm operates a network of more than 170\nstate-of-the-art facilities across the United States, with a team of over 220\nsurgeons focused on delivering the highest quality of oral health care and\ndental implant surgery while fostering a medically-driven, patient-friendly\nculture of excellence.\n\n\"This is an important milestone for Paradigm and for the surgeons who have\nbuilt this platform into what it is today,\" said Dr. David Rallis, Founder and\nChief Executive Officer of Paradigm. \"We are excited to partner with Warburg\nPincus and our new investors, who understand the strength of our surgeon-owned\nand surgeon-led model, the quality of our clinical culture and the significant\nopportunity ahead. We are grateful to BlackRock LTPC for their partnership and\nsupport in helping us reach this point and are excited to continue delivering\nexceptional clinical care to patients across the country.\"\n\n\"Paradigm has built a highly differentiated, surgeon-led clinical model that\ncombines excellent patient care with advanced education, robust clinical\ntechnology and a surgeon-first culture. We are thrilled to support Dr. Rallis\nand the Paradigm team in this next phase of growth,\" said Adam Krainson,\nManaging Director, Warburg Pincus. \"This investment reflects our focus on\npartnering with high-quality healthcare businesses that have strong clinical\nfoundations, meaningful growth potential and exceptional leadership teams,\nwhile providing flexible capital to support long-term growth.\" added José\nArredondo, Managing Director, Warburg Pincus. The investment is being made by\nthe Warburg Pincus Capital Solutions Founders Fund (\"WPCS FF\").\n\nJefferies served as financial advisor to the Company and BlackRock LTPC and\nGoodwin Procter LLP served as legal advisor to the Company.  Evercore served\nas financial advisor and Latham & Watkins LLP served as legal advisor to\nWarburg Pincus.\n\nAbout Paradigm Oral Health\n\nParadigm Oral Health is one of the nation's leading organizations for oral\nsurgery, partnering with elite oral surgeons to deliver exceptional patient\ncare through clinical excellence, innovation and education. By combining\nsurgeon leadership with advanced technology, operational support and a\ncommitment to continuous learning, Paradigm is helping shape the future of the\nspecialty while expanding access to world-class care across the United States.\nTo learn more, visit ParadigmOralHealth.com\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4736858-1&h=2005054540&u=http%3A%2F%2Fparadigmoralhealth.com%2F&a=ParadigmOralHealth.com)\nand Pi2edu.com\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4736858-1&h=2484487085&u=http%3A%2F%2Fpi2edu.com%2F&a=Pi2edu.com)\n.\n\nAbout Warburg Pincus\n\nWarburg Pincus LLC is the pioneer of global growth investing. A private\npartnership since 1966, the firm has the flexibility and experience to focus\non helping investors and management teams achieve enduring success across\nmarket cycles. Today, the firm has more than $105 billion in assets under\nmanagement, and more than 225 companies in its active portfolio, diversified\nacross stages, sectors, and geographies. Warburg Pincus has invested in more\nthan 1,100 companies across its private equity, real estate, and capital\nsolutions strategies. Since inception, Warburg Pincus has invested over $20\nbillion in more than 190 innovative healthcare companies around the world,\nincluding Summit Health/CityMD, MB2 Dental, Modernizing Medicine, GHX,\nEnsemble Healthcare Partners, and Bausch + Lomb.\n\nWarburg Pincus Capital Solutions collaborates closely with the firm's 290+\ninvestment professionals and approximately 75 value creation executives to\noffer flexible, solutions-oriented capital across sectors and geographies for\ngrowth, M&A, balance sheet optimization, and shareholder liquidity. The\ngroup works together with domain experts across Warburg Pincus' global\nindustry verticals to source and underwrite bespoke, value additive\ntransactions. Recent investments have included DriveCentric, Cerity Partners,\nExcelitas Technologies, Global Eggs, MB2 Dental, Madison International Realty,\nMIAX, MyKaarma, Nord Security, Service Compression, and United Trust Bank.\n\nThe firm is headquartered in New York with more than 15 offices globally. For\nmore information, please visit www.warburgpincus.com\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4736858-1&h=384082869&u=http%3A%2F%2Fwww.warburgpincus.com%2F&a=www.warburgpincus.com)\n or follow us on LinkedIn\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4736858-1&h=2732283456&u=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fwarburg-pincus%2F&a=LinkedIn)\n and YouTube\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4736858-1&h=4163524688&u=https%3A%2F%2Fwww.youtube.com%2F%40WarburgPincusLLC&a=YouTube)\n.\n\nAbout Goldman Sachs Alternatives\n\nGoldman Sachs (NYSE: GS) is one of the leading investors in alternatives\nglobally, with over $645 billion in assets and more than 30 years of\nexperience. The business invests in the full spectrum of alternatives,\nincluding private equity, growth equity, private credit, real estate,\ninfrastructure, sustainability, and hedge funds. Clients access these\nsolutions through direct strategies, customized partnerships, and\nopen-architecture programs.\n\nThe business is driven by a focus on partnership and shared success with its\nclients, seeking to deliver long-term investment performance drawing on its\nglobal network and deep expertise across industries and markets.\n\nThe alternative investments platform is part of Goldman Sachs Asset\nManagement, which delivers investment and advisory services across public and\nprivate markets for the world's leading institutions, financial advisors and\nindividuals. Goldman Sachs has more than $4 trillion in assets under\nsupervision globally as of June 30, 2026. Follow us on LinkedIn\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4736858-1&h=1670519697&u=https%3A%2F%2Furldefense.com%2Fv3%2F__https%3A%2Fwww.linkedin.com%2Fshowcase%2Fgoldman-sachs-assetmanagement%2F__%3B!!C6_QoRJkNIGUjYo!CXd3F92FRX-w1ePgdYUA8p-Xp_nE0U_tINqhg4K0ZFWIexKhEHUwGuth637FNta98jlNzES4k--fm5CdMoSeXx4l2LAEYdFo%24&a=LinkedIn)\n.\n\nAbout Sixth Street\n\nSixth Street is a global investment firm with over $135 billion in assets\nunder management and committed capital. Sixth Street uses its long-term\nflexible capital, data-enabled capabilities, and One Team culture to develop\nthemes and offer solutions to companies across all stages of growth. Sixth\nStreet Healthcare and Life Sciences invests thematically throughout the\nhealthcare ecosystem, providing flexible capital solutions to companies\naddressing our most pressing healthcare challenges and improving patient\noutcomes. Founded in 2009, Sixth Street has more than 750 team members\nincluding approximately 300 investment professionals around the world. For\nmore information, visit www.sixthstreet.com\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4736858-1&h=383106585&u=http%3A%2F%2Fwww.sixthstreet.com%2F&a=www.sixthstreet.com)\n, and follow Sixth Street on LinkedIn\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4736858-1&h=4029458253&u=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fsixthstreet%2F&a=LinkedIn)\n.\n\nContact\n\nParadigm Oral Health\n\nWill Garin\n\nWill.Garin@paradigmoralhealth.com (mailto:Will.Garin@paradigmoralhealth.com)\n\nWarburg Pincus\n\nSarah Bloom, Director, Communications\n\nsarah.bloom@warburgpincus.com (mailto:sarah.bloom@warburgpincus.com)\n\nView original\ncontent:https://www.prnewswire.com/news-releases/paradigm-oral-health-announces-surgeon-led-buyback-backed-by-warburg-pincus-led-investor-group-302832427.html\n(https://www.prnewswire.com/news-releases/paradigm-oral-health-announces-surgeon-led-buyback-backed-by-warburg-pincus-led-investor-group-302832427.html)\n\nSOURCE Warburg Pincus LLC\n\n\n\nCopyright (c) 2026 PR Newswire Association,LLC. All Rights Reserved."},"type":"article","timestamp":"2026-07-23T19:00:01.248679936Z","server_sent_at_ms":1784833201248},"received_at":"2026-07-23T19:00:01.299Z","source_url":"https://www.prnewswire.com/news-releases/paradigm-oral-health-announces-surgeon-led-buyback-backed-by-warburg-pincus-led-investor-group-302832427.html"},"analysis":{"id":"86176","press_release_id":"97133","analysis_json":{"industry":{"label":"Capital Markets","sector":"Financials"},"redFlags":[],"eventType":"partnership","narrative":"Goldman Sachs Alternatives joined a Warburg Pincus-led investor group to back a surgeon-led buyback of BlackRock Long Term Private Capital's stake in Paradigm Oral Health.\n\nParadigm operates a network of over 170 facilities with more than 220 surgeons, focusing on oral surgery and dental implants.\n\nThe transaction returns majority control to Paradigm's surgeons and management, with support from the new investor group to fund expansion and technology investments.","sentiment":"neutral","agentHooks":{"shouldPost":false,"suggestedAngle":"GS Alternatives co-invests in dental platform recapitalization alongside Warburg Pincus."},"keyFigures":{"customDimensions":{"surgeons":220,"facilities":170}},"quotedText":"This investment reflects our focus on partnering with high-quality healthcare businesses that have strong clinical foundations, meaningful growth potential and exceptional leadership teams","namedEntities":{"people":[{"name":"David Rallis","role":"Founder and CEO of Paradigm Oral Health"},{"name":"Adam Krainson","role":"Managing Director, Warburg Pincus"},{"name":"José Arredondo","role":"Managing Director, Warburg Pincus"},{"name":"Will Garin","role":"Contact, Paradigm Oral Health"},{"name":"Sarah Bloom","role":"Director of Communications, Warburg Pincus"}],"products":[],"companies":[{"name":"Paradigm Oral Health","relationship":"portfolio company"},{"name":"BlackRock Long Term Private Capital","relationship":"seller"},{"name":"Warburg Pincus","relationship":"lead investor"},{"name":"Goldman Sachs Alternatives","ticker":"GS","relationship":"investor"},{"name":"Sixth Street","relationship":"investor"},{"name":"Jefferies","relationship":"financial advisor"},{"name":"Evercore","relationship":"financial advisor"},{"name":"Goodwin Procter LLP","relationship":"legal advisor"},{"name":"Latham & Watkins LLP","relationship":"legal advisor"}],"dollarAmounts":[]},"materialImpact":{"score":1,"reasoning":"Goldman Sachs Alternatives is participating in a private equity-style investment alongside Warburg Pincus and Sixth Street. The deal size is not disclosed, and for an institution the size of GS, this single investment is likely immaterial to overall financial results."},"tickerRelevance":{"others":[],"primary":"GS"},"globalImportance":25,"audienceRelevance":45,"eventTypeSecondary":["operations_update"],"importanceComponents":{"dealValue":"undisclosed","tickerTier":"mega-cap","eventGravity":"private-co-investment","sectorWeight":"financials"}},"event_type":"partnership","event_type_secondary":["operations_update"],"sentiment":"neutral","material_impact_score":1,"narrative":"Goldman Sachs Alternatives joined a Warburg Pincus-led investor group to back a surgeon-led buyback of BlackRock Long Term Private Capital's stake in Paradigm Oral Health.\n\nParadigm operates a network of over 170 facilities with more than 220 surgeons, focusing on oral surgery and dental implants.\n\nThe transaction returns majority control to Paradigm's surgeons and management, with support from the new investor group to fund expansion and technology investments.","key_figures":{"customDimensions":{"surgeons":220,"facilities":170}},"named_entities":{"people":[{"name":"David Rallis","role":"Founder and CEO of Paradigm Oral Health"},{"name":"Adam Krainson","role":"Managing Director, Warburg Pincus"},{"name":"José Arredondo","role":"Managing Director, Warburg Pincus"},{"name":"Will Garin","role":"Contact, Paradigm Oral Health"},{"name":"Sarah Bloom","role":"Director of Communications, Warburg Pincus"}],"products":[],"companies":[{"name":"Paradigm Oral Health","relationship":"portfolio company"},{"name":"BlackRock Long Term Private Capital","relationship":"seller"},{"name":"Warburg Pincus","relationship":"lead investor"},{"name":"Goldman Sachs Alternatives","ticker":"GS","relationship":"investor"},{"name":"Sixth Street","relationship":"investor"},{"name":"Jefferies","relationship":"financial advisor"},{"name":"Evercore","relationship":"financial advisor"},{"name":"Goodwin Procter LLP","relationship":"legal advisor"},{"name":"Latham & Watkins LLP","relationship":"legal advisor"}],"dollarAmounts":[]},"model_name":"glm-4.7","prompt_hash":"sha256:727b4b9429a443af","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-07-23T21:17:13.275Z","global_importance":25,"audience_relevance":45,"importance_components":{"dealValue":"undisclosed","tickerTier":"mega-cap","eventGravity":"private-co-investment","sectorWeight":"financials"}},"durationMs":300266,"modelName":"glm-4.7"}}